Adaptive Biotechnologies Corporation (ADPT) vs CareDx, Inc. (CDNA)
- Adaptive Biotechnologies Corporation ADPT 24.02 −6.10%
- CareDx, Inc. CDNA 63.81 −4.30%
Adaptive Biotechnologies Corporation and CareDx, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.1B against $3.5B — 1.2× the size. Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against 34.4%. CareDx, Inc. has the higher net margin (24.2% vs −20.7%) and the higher return on invested capital (130.1% vs −16.6%). Across the 18 metrics below, CareDx, Inc. leads on 12 and Adaptive Biotechnologies Corporation on 6.
Valuation
Profitability
| Metric | ADPT | CDNA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 70.58% | 50.89% |
| Operating margin | (12.16%) | 23.61% | (8.57%) |
| Net margin | (20.73%) | 24.23% | (6.37%) |
| Free cash flow margin | (7.80%) | 18.49% | 0.00% |
| Return on equity | (38.68%) | 29.49% | (2.92%) |
| Return on assets | (11.23%) | 22.72% | (6.71%) |
| Return on invested capital | (16.57%) | 130.06% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack